Cataplexy and monoamine oxidase deficiency in Norrie disease

被引:27
作者
Vossler, DG [1 ]
Wyler, AR [1 ]
Wilkus, RJ [1 ]
GardnerWalker, G [1 ]
Vlcek, BW [1 ]
机构
[1] SWEDISH HLTH SERV,DIV CHILD NEUROL,SEATTLE,WA
关键词
D O I
10.1212/WNL.46.5.1258
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Norrie disease (ND) is an X-linked recessive disorder causing ocular atrophy, mental retardation, deafness, and dysmorphic features. Virtually absent monoamine oxidase (MAO) type-A and -B activity has been found in some boys with chromosome deletions. We report the coexistence of cataplexy and abnormal REM sleep organization with ND. Three related boys, referred for treatment of medically refractory atonic spells and apneas, underwent extended EEG-video-polysomnographic monitoring. They demonstrated attacks of cataplexy and inappropriate periods of REM sleep during which they were unarousable. One boy also had generalized tonic-clonic seizures. Previous testing revealed that all three have complete ND gene deletions. In all subjects, platelet MAO-B activity was absent, serum serotonin levels were markedly increased, and plasma catecholamine levels were normal. Data from the canine narcolepsy syndrome model implicate abnormal catecholaminergic and cholinergic activities in the pathogenesis of cataplexy. Our findings suggest that abnormal MAO activity or an imbalance between serotonin and other neurotransmitter levels may be involved in the pathogenesis of human cataplexy.
引用
收藏
页码:1258 / 1261
页数:4
相关论文
共 22 条
[1]  
Aldrich M. S., 1993, Neurophysiologie Clinique, V23, P35, DOI 10.1016/S0987-7053(05)80281-3
[2]  
BATEMAN JB, 1993, T AM OPHTHAL SOC, V9, P299
[3]   SEROTONIN SYNDROME [J].
BODNER, RA ;
LYNCH, T ;
LEWIS, L ;
KAHN, D .
NEUROLOGY, 1995, 45 (02) :219-223
[4]   EFFECTS OF MODAFINIL ON SYMPTOMATOLOGY OF HUMAN NARCOLEPSY [J].
BOIVIN, DB ;
MONTPLAISIR, J ;
PETIT, D ;
LAMBERT, C ;
LUBIN, S .
CLINICAL NEUROPHARMACOLOGY, 1993, 16 (01) :46-53
[5]   ISOLATION AND CHARACTERIZATION OF A CANDIDATE GENE FOR NORRIE DISEASE [J].
CHEN, ZY ;
HENDRIKS, RW ;
JOBLING, MA ;
POWELL, JF ;
BREAKEFIELD, XO ;
SIMS, KB ;
CRAIG, IW .
NATURE GENETICS, 1992, 1 (03) :204-208
[6]   CLINICAL, BIOCHEMICAL, AND NEUROPSYCHIATRIC EVALUATION OF A PATIENT WITH A CONTIGUOUS GENE SYNDROME DUE TO A MICRODELETION XP11.3 INCLUDING THE NORRIE DISEASE LOCUS AND MONOAMINE-OXIDASE (MAOA AND MAOB) GENES [J].
COLLINS, FA ;
MURPHY, DL ;
REISS, AL ;
SIMS, KB ;
LEWIS, JG ;
FREUND, L ;
KAROUM, F ;
ZHU, DP ;
MAUMENEE, IH ;
ANTONARAKIS, SE .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1992, 42 (01) :127-134
[7]   DETERMINATION OF A REFERENCE RANGE FOR WHOLE-BLOOD SEROTONIN IN A PEDIATRIC POPULATION USING HIGH-PRESSURE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION [J].
GOLDSMITH, BM ;
FEINSTEIN, C ;
MUNSON, S ;
REISS, A ;
BORENGASSERCARUSO, MA .
CLINICAL BIOCHEMISTRY, 1986, 19 (06) :359-363
[8]  
Guilleminault C, 1994, PRINCIPLES PRACTICE, V2, P549
[9]  
JOY J E, 1991, Applied and Theoretical Electrophoresis, V2, P3
[10]   BRAIN NEUROTRANSMITTER CHANGES IN HUMAN NARCOLEPSY [J].
KISH, SJ ;
MAMELAK, M ;
SLIMOVITCH, C ;
DIXON, LM ;
LEWIS, A ;
SHANNAK, K ;
DISTEFANO, L ;
CHANG, LJ ;
HORNYKIEWICZ, O .
NEUROLOGY, 1992, 42 (01) :229-234